ESS Tech, Inc. (GWH): Nasdaq/NYSE listing notice — ESS Tech receives NYSE deficiency notice for low stock price; 30-day avg $0.98

ESS Tech, Inc.

NYSE notified ESS on June 9, 2026, that average closing price below $1.00 over 30 trading days.
30-trading-day average closing price as of June 8 was $0.98.
Company has 6 months to regain compliance; considering reverse stock split.
Notice does not immediately affect listing or trading of GWH common stock on NYSE.
Company plans to notify NYSE of intent to cure within 10 business days.

item 3.01 item 7.01 item 9.01

Featured in Daily 8-K Digest

Selected #7 for 2026-06-15. Read digest

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ESS Tech, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

June 9, 2026, ESS Tech, Inc. (the “Company”) received a written notice (the “Notice”) from the New York Stock Exchange (“NYSE”) indicating that the Company did not satisfy the continued listing standard set forth in Section 802.01C of the NYSE Listed Company Manual (“Section 802.01C”), as the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period. As of June 8, 2026, the 30 trading-day average closing share price of the Company's common stock was $0.98. The Notice is a notice of deficiency, not delisting, and does not currentl

View on SEC.gov

95 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ESS Tech, Inc. filing history →

Source: SEC EDGAR

accession 0001819438-26-000044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.